The life expectancy of some prostate cancer patients could be lengthened with a natural, non-toxic substance called genistein-combined polysaccharide (GCP). The finding came from a new study on prostate cancer cells and mice conducted by researchers from University of California, Davis, and was published in Endocrine-Related Cancer. The men who have the highest probability to benefit from GCP are those with metastatic prostate cancer - cancer that has spread to other parts of the body - and have already used drug therapy to lower their testosterone levels...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment